Compare RZLT & FSTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RZLT | FSTR |
|---|---|---|
| Founded | 2010 | 1902 |
| Country | United States | United States |
| Employees | N/A | 1191 |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.4M | 280.8M |
| IPO Year | 2011 | 1995 |
| Metric | RZLT | FSTR |
|---|---|---|
| Price | $2.63 | $27.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 1 |
| Target Price | $9.17 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 1.6M | 17.3K |
| Earning Date | 05-27-2026 | 06-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 26.32 | N/A |
| EPS | N/A | ★ 0.69 |
| Revenue | N/A | ★ $540,009,000.00 |
| Revenue This Year | N/A | $5.44 |
| Revenue Next Year | N/A | $3.05 |
| P/E Ratio | ★ N/A | $39.48 |
| Revenue Growth | N/A | ★ 1.74 |
| 52 Week Low | $1.07 | $17.16 |
| 52 Week High | $11.46 | $32.63 |
| Indicator | RZLT | FSTR |
|---|---|---|
| Relative Strength Index (RSI) | 34.90 | 32.18 |
| Support Level | $1.87 | $25.62 |
| Resistance Level | $2.82 | $28.19 |
| Average True Range (ATR) | 0.26 | 1.40 |
| MACD | -0.05 | -0.51 |
| Stochastic Oscillator | 0.46 | 4.69 |
Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.
L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.